$24.86
Price
$12.4B
Market Cap
355.1
P/E Ratio
24.1
Forward P/E
$0.07
EPS (TTM)
—
Dividend Yield
$505M
Cash
$4.3B
Total Debt
497M
Shares Out
$8.02
$26.08
52-Week Range
Institutional Ownership of ELANCO ANIMAL HEALTH INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for ELANCO ANIMAL HEALTH INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | -0.2% | 82.8M | $1.7B | $17.46 | |
| 2025-Q2 | |||||
| SELL | -0.0% | 82.9M | $1.2B | $12.67 | |
| 2025-Q1 | |||||
| SELL | -0.3% | 82.9M | $871M | $11.32 | |
| 2024-Q4 | |||||
| SELL | -0.2% | 83.2M | $1.0B | $12.86 | |
| 2024-Q3 | |||||
| SELL | -0.3% | 83.3M | $1.2B | $14.07 | |
| 2024-Q2 | |||||
| SELL | -0.3% | 83.6M | $1.2B | $16.79 | |
| 2024-Q1 | |||||
| SELL | -0.2% | 83.8M | $1.4B | $15.82 | |
| SELL | EXIT | — | — | $15.82 | |
| 2023-Q4 | |||||
| SELL | -0.3% | 84.0M | $1.3B | $11.34 | |
| SELL | -82.9% | 13.4K | $200286 | $11.34 | |
| 2023-Q3 | |||||
| SELL | -0.5% | 84.2M | $946M | $11.75 | |
| SELL | -48.1% | 78.8K | $885645 | $11.75 | |
| 2023-Q2 | |||||
| SELL | -0.2% | 84.6M | $851M | $9.28 | |
| SELL | -29.3% | 151.9K | $2M | $9.28 | |
| 2023-Q1 | |||||
| SELL | +0.0% | 84.8M | $797M | $12.67 | |
| SELL | -3.9% | 214.7K | $2M | $12.67 | |
| 2022-Q4 | |||||
| BUY | +60.0% | 84.8M | $1.0B | $12.35 | |
| SELL | EXIT | — | — | $12.35 | |
| SELL | -13.9% | 223.4K | $3M | $12.35 | |
| 2022-Q3 | |||||
| BUY | +7.7% | 53.0M | $658M | $19.02 | |
| BUY | +1.9% | 4.1M | $51M | $19.02 | |
| SELL | -28.8% | 259.4K | $3M | $19.02 | |
| 2022-Q2 | |||||
| BUY | +72.1% | 49.2M | $966M | $24.13 | |
| SELL | -6.0% | 4.1M | $80M | $24.13 | |
| SELL | -12.4% | 364.4K | $7M | $24.13 | |
| 2022-Q1 | |||||
| BUY | +28.7% | 28.6M | $746M | $26.61 | |
| BUY | +46.5% | 4.3M | $113M | $26.61 | |
| SELL | -39.2% | 416.0K | $11M | $26.61 | |
| 2021-Q4 | |||||
| BUY | +510.5% | 22.2M | $631M | $32.10 | |
| BUY | +31.6% | 2.9M | $84M | $32.10 | |
| SELL | -40.2% | 684.0K | $19M | $32.10 | |
| 2021-Q3 | |||||
| BUY | NEW | 3.6M | $116M | $33.53 | |
| SELL | -3.2% | 2.2M | $71M | $33.53 | |
| SELL | -1.0% | 1.1M | $36M | $33.53 | |
| 2021-Q2 | |||||
| SELL | -0.8% | 2.3M | $80M | $33.52 | |
| SELL | -8.8% | 1.2M | $40M | $33.52 | |
| 2021-Q1 | |||||
| SELL | -6.8% | 2.3M | $69M | $30.59 | |
| SELL | -0.5% | 1.3M | $37M | $30.59 | |
| 2020-Q4 | |||||
| SELL | -15.9% | 2.5M | $77M | $30.49 | |
| SELL | -0.1% | 1.3M | $39M | $30.49 | |
| 2020-Q3 | |||||
| SELL | -28.0% | 3.0M | $83M | $25.77 | |
| BUY | +7.4% | 1.3M | $36M | $25.77 | |
| 2020-Q2 | |||||
| BUY | +8.3% | 4.1M | $89M | $22.16 | |
| BUY | +1.4% | 1.2M | $25M | $22.16 | |
| 2020-Q1 | |||||
| BUY | +6.8% | 3.8M | $85M | $29.10 | |
| BUY | +4.2% | 1.2M | $26M | $29.10 | |
| 2019-Q4 | |||||
| BUY | +2.6% | 3.6M | $105M | $26.92 | |
| BUY | +28.4% | 1.1M | $33M | $26.92 | |
| 2019-Q3 | |||||
| SELL | -3.0% | 3.5M | $92M | $29.74 | |
| BUY | +41.4% | 874.3K | $23M | $29.74 | |
| 2019-Q2 | |||||
| SELL | -0.6% | 3.6M | $121M | $32.50 | |
| BUY | +90.8% | 618.5K | $21M | $32.50 | |
| 2019-Q1 | |||||
| BUY | NEW | 3.6M | $116M | $30.60 | |
| BUY | NEW | 324.1K | $10M | $30.60 | |
| 2018-Q4 | |||||
| SELL | EXIT | — | — | $32.98 | |
| SELL | EXIT | — | — | $32.98 | |
| 2018-Q3 | |||||
| BUY | NEW | 2.0M | $70M | $34.90 | |
| BUY | NEW | 652.1K | $23M | $34.90 | |
Insider Trading for ELANCO ANIMAL HEALTH INC
6 Months Insider Sentiment
Buy $938K
Sell $0
4
Buys
0
Sells
+938K
Net
12
Grants
Largest
$478K
Simmons
$213K
Kurzius
$150K
Vanhimbergen
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 19, 2025 | David R Hoover | Director | GRANT | 60.0K | — | — |
| Dec 12, 2025 | Lawrence Erik Kurzius | Director | BUY | 10.0K | $21.30 | $213K |
| Dec 11, 2025 | Jeffrey N Simmons | PRESIDENT, CEO AND DIRECTOR | BUY | 22.0K | $21.75 | $478K |
| Dec 11, 2025 | Rajeev A. Modi | Executive Vice President U.S. Pet Health and Global Digital Transformation | BUY | 4.5K | $21.33 | $96K |
| Dec 11, 2025 | Robert M Vanhimbergen | EVP and CFO | BUY | 7.0K | $21.64 | $150K |
| Nov 28, 2025 | Kirk P Mcdonald | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Lawrence Erik Kurzius | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Michael J Harrington | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Paul Herendeen | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Stacey Ma | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | David R Hoover | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Deborah Turner Kochevar | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Denise Scots-Knight | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Kapila K Anand | Director | GRANT | 10.3K | — | — |
| Nov 28, 2025 | Art A Garcia | Director | GRANT | 10.3K | — | — |
| Oct 01, 2025 | Robert M Vanhimbergen | EVP and CFO | GRANT | 109.9K | — | — |